Prices verified August 31, 2026
9amHealth logo

9amHealth reviews: price, lock-in and our score

Best for diabetes and cardio risk
9amHealth does not publish a price. The figure below is our estimate from comparable programs, reviewed on August 31. How we verify →

9amHealth starts at an estimated $448/mo, reviewed August 31, 2026. It scores 7.3 out of 10. Cancel any time, no lock-in.

Built for diabetes and heart-risk patients, not weight loss alone.
Visit 9amHealth

Some visit links earn us a commission.

GLP CHART SCORE
7.3
OUT OF 10
Starts From (estimated)
$448/moEstimated
includes medication
Lock-In
Month-to-month
Time to prescription
5 days
Live
Rank
#12
GLP Chart Score

Verdict

At 9amHealth, GLP-1 is one tool inside a broader cardiometabolic program. Labs come included, medication is branded-first. Employer and insurance relationships are strong. Best fit for patients with comorbidities, not pure weight-loss buyers.

Pros

  • Full heart and metabolic care, not GLP-1 alone, with labs and a care team included.
  • $149/mo cash membership, or free with eligible insurance or employer coverage.
  • Branded GLP-1 first through retail pharmacy on insurance.
  • Strong employer benefits integration for covered patients.
  • Spanish-speaking clinicians and dietitian support available.

Cons

  • $149/mo membership excludes medication, branded Wegovy adds $500-$1,100/mo cash if not covered.
  • Five-day onboarding, slower than async-intake competitors.
  • GLP-1 is not the headline product. The program is built around diabetes and heart risk.
  • Limited compounded availability, brand-first sourcing.
  • App-only support channel.
Best for

Patients with diabetes, prediabetes or cardiovascular risk who want a GLP-1 inside full metabolic care.

Not for

Healthy BMI-only patients chasing the lowest GLP-1 price.

Pricing

About $448/mo cheapest cash estimate at maintenance (membership plus the $299 oral Wegovy; starter doses $149). 9amHealth handles insurance for branded GLP-1s; insured patients can pay much less. Exact membership fee confirmed at sign-up.

Estimated cash-pay all-in: $448/mo This price includes medication. 9amHealth does not publish a price. This is our estimate from comparable programs, not a confirmed rate.
Signup / one-timeNone
Membership / subscription$149/mo
Medication (varies by dose)$500–$1,086/mo
All-in, lowest maintenance doseVaries

Price since we started tracking

$448/mo down $201 since May 25
9amHealth headline maintenance price by week (USD per month)
WeekPrice
May 25$649/mo
Jun 1$649/mo
Jun 8$649/mo
Jun 15$649/mo
Jun 22$649/mo
Jun 29$448/mo
Jul 6$448/mo
Jul 13no public price
Jul 20no public price
Jul 27no public price
Aug 3no public price
Aug 10no public price
Aug 17no public price
Aug 24no public price
Aug 31no public price

Headline maintenance price, read off the program's published pricing every Monday. Tracking since May 2026, 15 checks so far. See the full price tracker.

See how 9amHealth compares with every path in our GLP-1 cost guide, or check the live price index for the full chart.

Lock-in & cancellation

Month-to-month

Cancel anytime from app or via support. No prepay tiers, no termination fee. Pro-rata for unused subscription period.

How to cancel: Month-to-month, cancel anytime from app or support, no prepay tiers, no termination fee, pro-rata refund for unused period.

Medication options

Branded GLP-1 through retail pharmacy on insurance or cash. Compounded available as fallback when branded inaccessible. Full diabetes and cardiovascular drug formulary.

About compounded GLP-1 in 2026.

A licensed US pharmacy makes compounded semaglutide and tirzepatide to a prescription. They are not FDA-approved and they are not Wegovy, Ozempic, Zepbound or Mounjaro. The FDA does not review them for safety, effectiveness or quality, and their formulation, including the salt form, can differ from the approved drug. Confirm the active ingredient and the pharmacy with the prescriber. The FDA removed semaglutide from the drug-shortage list in February 2025, which narrowed the legal basis for routine 503A compounding of exact-copy semaglutide. 9amHealth uses a personalized-formulation model: the compound adds an active ingredient such as vitamin B12. Some state pharmacy boards tightened oversight through 2025 and 2026. For the full background see our compounded vs FDA-approved breakdown.

FDA-approved branded

  • Wegovy
  • Zepbound
  • Ozempic
  • Mounjaro
  • Rybelsus

Compounded

  • Compounded semaglutide

Other medications

  • Metformin
  • SGLT2 inhibitors
  • Statins
  • Antihypertensives

The drug comparison table covers semaglutide vs tirzepatide on cost, side effects, and clinical evidence side by side.

Onboarding experience

Time to first prescription: 5 days.
Consultation type: Live video visit with NP or MD plus async follow-up.
Requirements: Health history, at-home labs (mailed kit), video visit. Full metabolic intake..

9amHealth reviews: what members report

Liked by patients who fit the profile (T2D, prediabetes, employer-sponsored). Less visible to retail GLP-1 shoppers because they don't lead with weight-loss marketing.

What works

  • Full metabolic care, not weight loss alone
  • Labs included
  • Strong employer benefits integration
  • Diabetes expertise

What to watch

  • Slower onboarding
  • GLP-1 not the headline product
  • Limited compounded availability
  • App-only support channel

How we scored 9amHealth

Five dimensions, ten points each, weighted equally. Overall is the simple average.

7
Pricing
Transparency
8
Cancellation
Terms
6
Onboarding
Experience
7
Medication
Options
8.4
Member
Reviews

The member-reviews pillar reflects 9amHealth’s Trustpilot rating of 4.2/5. See it on Trustpilot →

Read the full methodology →

Ready to start with 9amHealth?Visit 9amHealth

Frequently asked questions

Is 9amHealth legit?
Yes. 9amHealth is a real, operating GLP-1 telehealth service that connects you with a licensed US clinician and a pharmacy. On our independent review it scores 7.3 out of 10, graded on pricing transparency, cancellation terms, onboarding, medication options and member reviews. 9amHealth does not publish a price; our figure is an estimate from comparable programs. It bills month-to-month with no lock-in. To decide whether it fits your budget and needs, read the verdict and the full score breakdown above.
Is 9amHealth a scam?
No. We found no evidence that 9amHealth is a scam. It is a functioning telehealth program with licensed prescribers, real medication and a published cancellation policy, not a fake storefront. The caveats are in our score of 7.3 out of 10: pricing and the maintenance-dose total are the things to check, since the advertised figure is often the starter dose. Compare it against the rest of the chart before deciding.
Is 9amHealth only for diabetics?
No, but their clinical model is built around cardiometabolic risk. They serve T2D, prediabetes, hypertension, lipid disorders and obesity, often in combination.
Can I get GLP-1 through my employer plan?
Often yes. 9amHealth contracts with several large employer health plans where GLP-1 may be covered with reduced or zero copay. Check eligibility at signup.
Do they require lab work?
Yes. Baseline labs are part of standard onboarding via mailed at-home kit, included in the membership fee.

Partner programs

If 9amHealth isn't the right fit, here are three programs to consider next:

These programs pay GLP Chart a commission when you join. Disclosure

See the full chart →

Before committing to a cash-pay path, check whether your insurance covers a GLP-1 at the payer coverage center. On Medicaid, see Medicaid GLP-1 coverage by state first. If you need PA paperwork, the prior authorization letter library has templates for all major plans. Already denied? The appeal letter library has 120 templates by denial reason.

Learn the category before you commit

Read these before signing up for any GLP-1 telehealth program, 9amHealth included:

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.